Lexaria Bioscience develops DehydraTECH, a patented oral drug delivery technology that enhances bioavailability of active pharmaceutical ingredients including GLP-1/GIP drugs, antivirals, cannabinoids, and others across indications like diabetes, weight loss, and epilepsy.
